DJIA 17,071.22 -41.93 -0.25%
NASDAQ 4,505.85 -6.34 -0.14%
S&P 500 1,977.80 -5.05 -0.25%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

38.39 -2.98 (-7.20%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SGEN $38.39 -7.20%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $40.93
Previous Close $41.37
Daily Range $37.80 - $40.93
52-Week Range $32.35 - $55.99
Market Cap $4.7B
P/E Ratio -68.95
Dividend (Yield) $0.00 (0.0%)
Volume 2,033,698
Average Daily Volume 807,049
Current FY EPS -$0.82

Sector

Healthcare

Industry

Drugs

Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website: http://www.seattlegenetics.com/

News & Commentary

Are Investors Wrong About Celldex Therapeutics?

Short-sellers have been pushing into Celldex Therapeutics this year. Here's why.

Weak On High Volume: Seattle Genetics (SGEN)

Seattle Genetics Seeks Expanded Use of Lymphoma Drug Following Study Win

Sector Update: Health-Care Shares Sink in Pre-Market Trade

Sector Update: Health Care

Seattle Genetics' Adcetris Positive in Durability Analysis - Analyst Blog

Seattle Genetics' Adcetris Positive in Durability Analysis - Analyst Blog

Interesting SGEN Put And Call Options For November 22nd

Seattle Genetics Offers Updated Progression-Free Survival, Overall Survival Data from ADCETRIS Front

Seattle Genetics Offers Updated Progression-Free Survival, Overall Survival Data from ADCETRIS Frontline PTCL Phase 1 Trial

Merck KGaA Teams Up with Sutro for ADCs Targeting Cancer - Analyst Blog

'Mad Money' Lightning Round: Buy, Buy, Buy Flextronics

Seattle Genetics (SGEN) Shares Cross Below 200 DMA

See More SGEN News...

SGEN's Top Competitors

SGEN $38.39 (-7.20%)
Current stock: SGEN
AMGN $140.07 (-0.70%)
Current stock: AMGN
GILD $107.51 (-0.80%)
Current stock: GILD
BIIB $330.16 (-1.01%)
Current stock: BIIB